| Recruitment status | Enrolling by invitation |
| Unique ID issued by UMIN | UMIN000012727 |
| Receipt No. | R000014868 |
| Official scientific title of the study | Prospective observational study evaluating clinical significance of serial quantification of PCT in respiratory diseases |
| Date of disclosure of the study information | 2013/12/29 |
| Last modified on | 2016/04/04 (Ver. 2) |
| Basic information | ||
| Official scientific title of the study | Prospective observational study evaluating clinical significance of serial quantification of PCT in respiratory diseases | |
| Title of the study (Brief title) | PCT in CAP | |
| Region |
|
|
| Condition | |||
| Condition | Respiratory diseases | ||
| Classification by specialty |
|
||
| Classification by malignancy | Others | ||
| Genomic information | NO | ||
| Objectives | |
| Narrative objectives1 | To clarify clinical significances of serial quantification of PCT in respiratory diseases. |
| Basic objectives2 | Others |
| Basic objectives -Others | To evaluate an usefulness of PCT as a prognositic biomarker of respiratoty diseases |
| Trial characteristics_1 | Exploratory |
| Trial characteristics_2 | Pragmatic |
| Developmental phase | Not applicable |
| Assessment | |
| Primary outcomes | 30 day mortality |
| Key secondary outcomes | Severity, initial treatment failure, causative pathogen of infectious diseases |
| In outcomes field, the entry of just a few words such as "safety" or "efficiency" will not be accepted. Specify the name of outcome measures, including the time when you plan to measure. Usually, only one primary outcome is accepted. Write the other outcomes in "secondary outcomes" field. |
| Base | |
| Study type | Observational |
| Study design | |
| Basic design | |
| Randomization | |
| Randomization unit | |
| Blinding | |
| Control | |
| Stratification | |
| Dynamic allocation | |
| Institution consideration | |
| Blocking | |
| Concealment | |
| Intervention | |
| No. of arms | |
| Purpose of intervention | |
| Type of intervention | |
| Interventions/Control_1 | |
| Interventions/Control_2 | |
| Interventions/Control_3 | |
| Interventions/Control_4 | |
| Interventions/Control_5 | |
| Interventions/Control_6 | |
| Interventions/Control_7 | |
| Interventions/Control_8 | |
| Interventions/Control_9 | |
| Interventions/Control_10 | |
| In interventions field, include the details of interventions, such as duration, amount, and frequency. If the intervention includes prescription or use of medical devices, duration is required. |
| Eligibility | ||||
| Age-lower limit |
|
|||
| Age-upper limit |
|
|||
| Gender | Male and Female | |||
| Key inclusion criteria | Patients with respiratory diseases
Healthy individuals as control |
|||
| Key exclusion criteria | Patients without lung diseases | |||
| Target sample size | 500 | |||
| Research contact person | |
| Name of lead principal investigator | Masato Watanabe |
| Organization | Fukujuji Hopital |
| Division name | Respiratory Medicine Division |
| Address | 3-1-24 Matsuyama, Kiyose, Tokyo, Japan |
| TEL | 042-491-4111 |
| masatowa1973@gmail.com | |
| Public contact | |
| Name of contact person | Masato Watanabe |
| Organization | Fukujuji Hopital |
| Division name | Respiratory Medicine Division |
| Address | 3-1-24 Matsuyama, Kiyose, Tokyo, Japan |
| TEL | 042-491-4111 |
| Homepage URL | |
| masatowa1973@gmail.com | |
| Sponsor | |
| Institute | Respiratory Medicine Division, Fukujuji Hospital |
| Institute | |
| Department | |
| Sponsor means an organization that is responsible for plan, deployment and report of the research including funding management. It doesn't mean funding agency". Therefore, all clinical trial should have the one. |
| Funding Source | |
| Organization | Wako Pure Chemical Industries, Ltd. |
| Organization | |
| Division | |
| Category of Funding Organization | Profit organization |
| Nationality of Funding Organization | Japan |
| Other related organizations | |
| Co-sponsor | Kyorin University |
| Name of secondary funder(s) | |
| Secondary IDs | |
| Secondary IDs | NO |
| Study ID_1 | |
| Org. issuing International ID_1 | |
| Study ID_2 | |
| Org. issuing International ID_2 | |
| IND to MHLW | |
| Institutions | |
| Institutions | 複十字病院、杏林大学 |
| Other administrative information | |||||||
| Date of disclosure of the study information |
|
||||||
| Progress | |||||||
| Recruitment status | Enrolling by invitation | ||||||
| Date of protocol fixation |
|
||||||
| Anticipated trial start date |
|
||||||
| Last follow-up date |
|
||||||
| Date of closure to data entry |
|
||||||
| Date trial data considered complete |
|
||||||
| Date analysis concluded |
|
||||||
| Related information | |
| URL releasing protocol | |
| Publication of results | Unpublished |
| URL releasing results | |
| Results | |
| Other related information | Randam sampling |
| Management information | |||||||
| Registered date |
|
||||||
| Last modified on |
|
||||||
| Link to view the page | |
| URL(English) | https://upload.umin.ac.jp/cgi-bin/ctr_e/ctr_view.cgi?recptno=R000014868 |